VOR BIOPHARMA INC (VOR) Institutional Shareholders
VOR BIOPHARMA INC (VOR) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $892.98M in VOR holdings during the latest filing period.
Tcg Crossover Management, Llc is currently the largest disclosed institutional shareholder of VOR tracked by InsiderSet, reporting ownership valued at approximately $104.44M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $121.40M, representing an estimated gain of +16.24% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 68% of the total disclosed VOR value among the investors covered in this analysis. Major shareholders include Tcg Crossover Management, Llc, Fmr Llc, Fcpm Iii Services B.V., and several other long-term asset managers with concentrated positions in VOR BIOPHARMA INC (VOR).
This page ranks the largest institutional VOR shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
100
Total Reported Value
$892.98M
Largest Holder
Tcg Crossover Management, Llc
Largest Position
$104.44M
Insider Transactions (90d)
0
Latest Filing Quarter
Q2 2026
New Institutional Positions
125
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Tcg Crossover Management, Llc | 2.51% | 5,673,078 | $104,441,366 | $121,403,869 | +$16,962,503 | +16.24% | |
| Fmr Llc | 0.00% | 4,932,149 | $90,800,863 | $105,547,989 | +$14,747,126 | +16.24% | |
| Fcpm Iii Services B.V. | 10.10% | 4,117,354 | $75,800,487 | $88,111,376 | +$12,310,889 | +16.24% | |
| Blackrock, Inc. | 0.00% | 3,468,107 | $63,847,850 | $74,217,490 | +$10,369,640 | +16.24% | |
| Venrock Adviser, Llc | 1.70% | 3,041,719 | $55,998,047 | $65,092,787 | +$9,094,740 | +16.24% | |
| State Street Corp | 0.00% | 2,616,336 | $48,166,746 | $55,989,590 | +$7,822,844 | +16.24% | |
| Frazier Life Sciences Management, L.P. | 1.02% | 2,543,939 | $46,833,917 | $54,440,295 | +$7,606,378 | +16.24% | |
| Ra Capital Management, L.P. | 0.38% | 2,402,095 | $44,222,569 | $51,404,833 | +$7,182,264 | +16.24% | |
| Vanguard Capital Management Llc | 0.00% | 2,084,328 | $38,372,478 | $44,604,619 | +$6,232,141 | +16.24% | |
| Caligan Partners Lp | 1.71% | 1,925,066 | $35,440,465 | $41,196,412 | +$5,755,947 | +16.24% | |
| Paradigm Biocapital Advisors Lp | 0.60% | 1,750,000 | $32,217,500 | $37,450,000 | +$5,232,500 | +16.24% | |
| Great Point Partners Llc | 7.37% | 1,700,000 | $31,297,000 | $36,380,000 | +$5,083,000 | +16.24% | |
| Geode Capital Management, Llc | 0.00% | 1,062,469 | $19,563,726 | $22,736,837 | +$3,173,111 | +16.22% | |
| Nextbio Capital Management Lp | 7.53% | 889,164 | $16,369,509 | $19,028,110 | +$2,658,601 | +16.24% | |
| Nantahala Capital Management, Llc | 0.94% | 845,000 | $15,556,450 | $18,083,000 | +$2,526,550 | +16.24% | |
| Adar1 Capital Management, Llc | 0.59% | 680,626 | $12,530,325 | $14,565,396 | +$2,035,071 | +16.24% | |
| Logos Global Management Lp | 0.52% | 650,000 | $11,966,500 | $13,910,000 | +$1,943,500 | +16.24% | |
| Rosalind Advisors, Inc. | 4.49% | 648,600 | $11,940,726 | $13,880,040 | +$1,939,314 | +16.24% | |
| Nan Fung Trinity (Hk) Ltd | 1.18% | 646,550 | $11,902,986 | $13,836,170 | +$1,933,184 | +16.24% | |
| Braidwell Lp | 0.39% | 573,104 | $10,550,845 | $12,264,426 | +$1,713,581 | +16.24% | |
| Boothbay Fund Management, Llc | 0.19% | 558,702 | $10,285,704 | $11,956,223 | +$1,670,519 | +16.24% | |
| Ubs Group Ag | 0.00% | 493,278 | $9,081,248 | $10,556,149 | +$1,474,901 | +16.24% | |
| Millennium Management Llc | 0.01% | 428,067 | $7,880,713 | $9,160,634 | +$1,279,921 | +16.24% | |
| Sphera Funds Management Ltd. | 1.10% | 416,417 | $7,666,237 | $8,911,324 | +$1,245,087 | +16.24% | |
| Woodline Partners Lp | 0.02% | 379,723 | $6,990,700 | $8,126,072 | +$1,135,372 | +16.24% | |
| Vanguard Portfolio Management Llc | 0.00% | 340,364 | $6,266,101 | $7,283,790 | +$1,017,689 | +16.24% | |
| Goldman Sachs Group Inc | 0.00% | 328,892 | $6,054,902 | $7,038,289 | +$983,387 | +16.24% | |
| Northern Trust Corp | 0.00% | 328,742 | $6,052,141 | $7,035,079 | +$982,938 | +16.24% | |
| Vanguard Fiduciary Trust Co | 0.00% | 300,704 | $5,535,961 | $6,435,066 | +$899,105 | +16.24% | |
| Clearline Capital Lp | 0.34% | 285,276 | $5,251,931 | $6,104,906 | +$852,975 | +16.24% | |
| Bank Of America Corp | 0.00% | 177,739 | $3,272,175 | $3,803,615 | +$531,440 | +16.24% | |
| Citadel Advisors Llc | 0.00% | 160,414 | $2,953,222 | $3,432,860 | +$479,638 | +16.24% | |
| Eversept Partners, Lp | 0.15% | 149,681 | $2,755,627 | $3,203,173 | +$447,546 | +16.24% | |
| Charles Schwab Investment Management Inc | 0.00% | 121,398 | $2,234,937 | $2,597,917 | +$362,980 | +16.24% | |
| Bank Of New York Mellon Corp | 0.00% | 97,722 | $1,799,062 | $2,091,251 | +$292,189 | +16.24% | |
| Marshall Wace, Llp | 0.00% | 95,643 | $1,760,788 | $2,046,760 | +$285,972 | +16.24% | |
| Nuveen, Llc | 0.00% | 94,815 | $1,745,544 | $2,029,041 | +$283,497 | +16.24% | |
| Axiom Investors Llc | 0.01% | 92,105 | $1,695,653 | $1,971,047 | +$275,394 | +16.24% | |
| Xtx Topco Ltd | 0.02% | 82,645 | $1,521,494 | $1,768,603 | +$247,109 | +16.24% | |
| Jump Financial, Llc | 0.01% | 70,889 | $1,305,066 | $1,517,025 | +$211,959 | +16.24% | |
| Invesco Ltd. | 0.00% | 68,301 | $1,257,421 | $1,461,641 | +$204,220 | +16.24% | |
| Citigroup Inc | 0.00% | 63,130 | $1,162,224 | $1,350,982 | +$188,758 | +16.24% | |
| Morgan Stanley | 0.00% | 61,561 | $1,133,338 | $1,317,405 | +$184,067 | +16.24% | |
| Rhumbline Advisers | 0.00% | 57,528 | $1,059,081 | $1,231,099 | +$172,018 | +16.24% | |
| Alps Advisors Inc | 0.00% | 54,998 | $1,012,513 | $1,176,957 | +$164,444 | +16.24% | |
| D. E. Shaw & Co., Inc. | 0.00% | 54,671 | $1,006,493 | $1,169,959 | +$163,466 | +16.24% | |
| Johnson & Johnson | 0.12% | 53,732 | $989,206 | $1,149,865 | +$160,659 | +16.24% | |
| Rafferty Asset Management, Llc | 0.00% | 48,818 | $898,739 | $1,044,705 | +$145,966 | +16.24% | |
| Walleye Capital Llc | 0.00% | 46,612 | $858,127 | $997,497 | +$139,370 | +16.24% | |
| Price T Rowe Associates Inc | 0.00% | 41,815 | $770,000 | $894,841 | +$124,841 | +16.21% |
Frequently asked questions about VOR
Who owns the most VOR stock?
The largest holders of VOR are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for VOR BIOPHARMA INC (VOR).
Is VOR widely held by superinvestors?
Many widely followed stocks like VOR appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly VOR is represented among the institutional managers we track.
What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?
Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.